T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? / Dominguez, Helena.
I: Atherosclerosis Supplements, 2005.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Dominguez, H 2005, 'T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?', Atherosclerosis Supplements.
APA
Dominguez, H. (2005). T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? Atherosclerosis Supplements.
Vancouver
Dominguez H. T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? Atherosclerosis Supplements. 2005.
Author
Bibtex
@article{3aa8318c2e2a4021a261e432513025e8,
title = "T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?",
author = "Helena Dominguez",
year = "2005",
language = "Udefineret/Ukendt",
journal = "Atherosclerosis Plus",
issn = "2667-0909",
publisher = "Elsevier Ireland Ltd",
}
RIS
TY - JOUR
T1 - T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?
AU - Dominguez, Helena
PY - 2005
Y1 - 2005
M3 - Tidsskriftartikel
JO - Atherosclerosis Plus
JF - Atherosclerosis Plus
SN - 2667-0909
ER -
ID: 303684789